Synopsis
Synopsis
0
VMF
0
Canada
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (2-(4-((r)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
2. (2-(4-((r)-p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic Acid
3. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
4. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Dihydrochloride
5. Cetirizine (r)-form Dihydrochloride
6. Levocetirizine
7. Levocetirizine Hydrochloride
8. Levocetrizine
9. Ucb-28556
10. Xusal
11. Xyzal
1. 130018-87-0
2. Xyzal
3. Xusal
4. (r)-cetirizine Dihydrochloride
5. Levocetirizine Hcl
6. Levocetirizine Dihydrochloride [usan]
7. Cetirizine (r)-form Dihydrochloride
8. Ucb-28556
9. Sod6a38aga
10. Ucb 28556
11. (2-(4-((r)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
12. (r)-2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
13. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Dihydrochloride
14. Nsc-758898
15. Levocetirizine Hydrochloride (jan)
16. (-)-cetirizine Dihydrochloride
17. 2-[2-[4-[(r)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid;dihydrochloride
18. 2-[2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid Dihydrochloride
19. Levocetirizine (dihydrochloride)
20. Levocetirizine Hydrochloride [jan]
21. Levocetirizine 2hcl
22. Unii-sod6a38aga
23. Levocetirizine Dihcl
24. Mfcd07366507
25. Xyzal Allergy 24hr
26. Xyzal (tn)
27. Levocetirizinedihydrochloride
28. Schembl144375
29. Chembl1201190
30. Levocetirizine Hydrochloride,(s)
31. Dtxsid30926567
32. Bcp21544
33. Ac-549
34. Levocetirizine Dihydrochloride (usp)
35. S4849
36. Akos015994681
37. Ccg-269359
38. Cs-w011557
39. Hy-w010841
40. Ks-1177
41. Nsc 758898
42. [2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic Acid 2hcl
43. 2-[2-[4-[(r)-(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride
44. Levocetirizine Hydrochloride [mart.]
45. L0264
46. Levocetirizine Dihydrochloride [vandf]
47. Levocetirizine(r)-cetirizine (hydrochloride)
48. D08118
49. Levocetirizine Dihydrochloride [usp-rs]
50. Levocetirizine Dihydrochloride [who-dd]
51. Levocetirizine Dihydrochloride, >=98% (hplc)
52. Cetirizine (r)-form Dihydrochloride [mi]
53. 018l870
54. Levocetirizine Dihydrochloride [orange Book]
55. Levocetirizine Dihydrochloride [usp Monograph]
56. Q27289313
57. [2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic Acid Dihydrochloride
Molecular Weight | 461.8 g/mol |
---|---|
Molecular Formula | C21H27Cl3N2O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 460.108726 g/mol |
Monoisotopic Mass | 460.108726 g/mol |
Topological Polar Surface Area | 53 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 443 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 4 | |
---|---|
Drug Name | Levocetirizine dihydrochloride |
Drug Label | Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets, is an orally active H1-receptor antagonist. The chemical name is R-(+)-2-[2-[4-[(4-chlorophenyl) phenyl methyl] piperazin-1-yl] ethoxy] acetic acid dihydr... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Synthon Pharms; Apotex; Hetero Labs Ltd Iii; Sciegen Pharms; Taro Pharm Inds; Sun Pharma Global; Glenmark Generics; Teva Pharms; Micro Labs Ltd India; Dr Reddys Labs; L Perrigo |
2 of 4 | |
---|---|
Drug Name | Xyzal |
PubMed Health | Levocetirizine (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an orally active H1receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride.... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Ucb |
3 of 4 | |
---|---|
Drug Name | Levocetirizine dihydrochloride |
Drug Label | Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets, is an orally active H1-receptor antagonist. The chemical name is R-(+)-2-[2-[4-[(4-chlorophenyl) phenyl methyl] piperazin-1-yl] ethoxy] acetic acid dihydr... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Synthon Pharms; Apotex; Hetero Labs Ltd Iii; Sciegen Pharms; Taro Pharm Inds; Sun Pharma Global; Glenmark Generics; Teva Pharms; Micro Labs Ltd India; Dr Reddys Labs; L Perrigo |
4 of 4 | |
---|---|
Drug Name | Xyzal |
PubMed Health | Levocetirizine (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an orally active H1receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride.... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Ucb |
Histamine H1 Antagonists, Non-Sedating
A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : DMF, EXCiPAT, KOSHER, HALAL, W...
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Silicified Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Sallyso (Croscarmellose Sodium) is a cross-linked polymer of carboxymethylcellulose sodium, used as a superdisintegrant in tablets and capsules.
Pharmacopoeia Ref : USP-NF, BP, IP, EP, DMF, EXCiP...
Technical Specs : Sallyso 0.5 to 3.0%
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Starlose P40 (Starch & Lactose Monohydrate) is used as a diluent in oral dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : Sucrex (Sucralose) is used as a sweetener and a taste masking agent in oral dosage forms such as tablets.
Pharmacopoeia Ref : USP-NF, BP, IP, EP, DMF, EXCiP...
Technical Specs : NA
Ingredient(s) : Sucralose
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90-...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90-...
Ingredient(s) : Lactose Monohydrate
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 716 g/l, Bulk density- 599 g/l; Particle size- D10-50 ?m, D50- 120 ?m, D90-...
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Pharmacopoeia Ref : Conforms to Ph. Eur., Lactose ...
Technical Specs : Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle size- D10-15 ?m, D50- 170 ?m, D90-...
Ingredient(s) : Anhydrous Lactose
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
Levocetirizine Dihydrochloride (200 mg)
CAS Number : 130018-87-0
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1359969
Current Lot : F02180
Previous Lot :
NDC Code :
CAS Number : 909779-33-5
Quantity Per Vial :
Price ($) : 715
Catalog Number : 1359958
Current Lot : F02170
Previous Lot :
NDC Code :
Levocetirizine Hydrochloride Impurity E
CAS Number : 682323-77-9
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : C0010.31
Levocetirizine Hydrochloride Impurity F HCl
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : C0010.45
Levocetirizine Hydrochloride Impurity G
CAS Number : 109806-71-5
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : C0010.30
Levocetirizine Hydrochloride Impurity LC-2
CAS Number : 113740-61-7
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : C0010.05
Levocetirizine Hydrochloride Impurity LC-5
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : C0010.46
Levocetrizine S-Isomer Impurity
CAS Number : 163837-48-7
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : L0004.10
Levocetirizine dihydrochloride
CAS Number : 130018-87-0
Quantity Per Vial :
Sale Unit :
Price :
Details : Creative peptides is specialized in the proce...
Monograph :
Storage :
Code/Batch No : Z10-101-136
CAS Number : 909779-33-5
Quantity Per Vial : 75
Sale Unit : mg
Price : $798.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1359958 / F02170
Levocetirizine Dihydrochloride (200 mg)
CAS Number : 130018-87-0
Quantity Per Vial : 200
Sale Unit : mg
Price : $245.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1359969 / F02180
ANALYTICAL
ABOUT THIS PAGE
59
PharmaCompass offers a list of Levocetirizine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levocetirizine Dihydrochloride manufacturer or Levocetirizine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levocetirizine Dihydrochloride manufacturer or Levocetirizine Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Levocetirizine Dihydrochloride API Price utilized in the formulation of products. Levocetirizine Dihydrochloride API Price is not always fixed or binding as the Levocetirizine Dihydrochloride Price is obtained through a variety of data sources. The Levocetirizine Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levocetirizine 2HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levocetirizine 2HCl, including repackagers and relabelers. The FDA regulates Levocetirizine 2HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levocetirizine 2HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levocetirizine 2HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levocetirizine 2HCl supplier is an individual or a company that provides Levocetirizine 2HCl active pharmaceutical ingredient (API) or Levocetirizine 2HCl finished formulations upon request. The Levocetirizine 2HCl suppliers may include Levocetirizine 2HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Levocetirizine 2HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levocetirizine 2HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Levocetirizine 2HCl active pharmaceutical ingredient (API) in detail. Different forms of Levocetirizine 2HCl DMFs exist exist since differing nations have different regulations, such as Levocetirizine 2HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levocetirizine 2HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Levocetirizine 2HCl USDMF includes data on Levocetirizine 2HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levocetirizine 2HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levocetirizine 2HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levocetirizine 2HCl Drug Master File in Japan (Levocetirizine 2HCl JDMF) empowers Levocetirizine 2HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levocetirizine 2HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Levocetirizine 2HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levocetirizine 2HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levocetirizine 2HCl Drug Master File in Korea (Levocetirizine 2HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levocetirizine 2HCl. The MFDS reviews the Levocetirizine 2HCl KDMF as part of the drug registration process and uses the information provided in the Levocetirizine 2HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levocetirizine 2HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levocetirizine 2HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levocetirizine 2HCl suppliers with KDMF on PharmaCompass.
A Levocetirizine 2HCl CEP of the European Pharmacopoeia monograph is often referred to as a Levocetirizine 2HCl Certificate of Suitability (COS). The purpose of a Levocetirizine 2HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levocetirizine 2HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levocetirizine 2HCl to their clients by showing that a Levocetirizine 2HCl CEP has been issued for it. The manufacturer submits a Levocetirizine 2HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levocetirizine 2HCl CEP holder for the record. Additionally, the data presented in the Levocetirizine 2HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levocetirizine 2HCl DMF.
A Levocetirizine 2HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levocetirizine 2HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levocetirizine 2HCl suppliers with CEP (COS) on PharmaCompass.
A Levocetirizine 2HCl written confirmation (Levocetirizine 2HCl WC) is an official document issued by a regulatory agency to a Levocetirizine 2HCl manufacturer, verifying that the manufacturing facility of a Levocetirizine 2HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levocetirizine 2HCl APIs or Levocetirizine 2HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Levocetirizine 2HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Levocetirizine 2HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levocetirizine 2HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levocetirizine 2HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levocetirizine 2HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levocetirizine 2HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levocetirizine 2HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levocetirizine 2HCl suppliers with NDC on PharmaCompass.
Levocetirizine 2HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levocetirizine 2HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levocetirizine 2HCl GMP manufacturer or Levocetirizine 2HCl GMP API supplier for your needs.
A Levocetirizine 2HCl CoA (Certificate of Analysis) is a formal document that attests to Levocetirizine 2HCl's compliance with Levocetirizine 2HCl specifications and serves as a tool for batch-level quality control.
Levocetirizine 2HCl CoA mostly includes findings from lab analyses of a specific batch. For each Levocetirizine 2HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levocetirizine 2HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Levocetirizine 2HCl EP), Levocetirizine 2HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levocetirizine 2HCl USP).